Inventor · disambiguated record
Akira Komoriya
Also filed as: KOMORIYA AKIRA
16 granted patents·10 pending applications·558 citations·filing 1985–2024
95Inventor score
Top patents by PatentIndex Score
26 records- 0195US6037137AFluorogenic peptides for the detection of protease activityONCOIMMUNIN INC·Filed 1997·Granted Mar 14, 2000·166 cites·38 claims
- 0293US7879574B2Compositions for the detection of enzyme activity in biological samples and methods of use thereofONCOIMMUNIN INC·Filed 2007·Granted Feb 1, 2011·15 cites·20 claims
- 0393US5605809ACompositions for the detection of proteases in biological samples and methods of use thereofONCOIMMUNIN INC·Filed 1994·Granted Feb 25, 1997·135 cites·33 claims
- 0491US7927871B2Visualization and quantitation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markersONCOIMMUNIN INC·Filed 2007·Granted Apr 19, 2011·19 cites·35 claims
- 0590US5714342ACompositions for the detection of protease in biological samples and methods of use therefoONCOIMMUNIN INC·Filed 1995·Granted Feb 3, 1998·77 cites·45 claims
- 0688US11261443B2In vivo delivery of oligonucleotidesONCOLMMUNIN INC·Filed 2019·Granted Mar 1, 2022·2 cites·16 claims
- 0788US6893868B2Homo-doubly labeled compositions for the detection of enzyme activity in biological samplesONCO IMMUNIN INC·Filed 2000·Granted May 17, 2005·22 cites·18 claims
- 0885US2024401040A1In vivo delivery of oligonucleotidesONCOIMMUNIN INC·Filed 2024·Application pending·0 cites
- 0979US7541143B2Homo-doubly labeled compositions for the detection of enzyme activity in biological samplesONCOIMMUNIN INC·Filed 2004·Granted Jun 2, 2009·4 cites·35 claims
- 1076US10557136B2In vivo delivery of oligonucleotidesONCOLMMUNIN INC·Filed 2012·Granted Feb 11, 2020·2 cites·21 claims
- 1174US6936687B1Compositions for the detection of enzyme activity in biological samples and methods of use thereofONCO IMMUNIN INC·Filed 1999·Granted Aug 30, 2005·34 cites·15 claims
- 1274US4751286AProtein label and drug delivery systemUNIV JOHNS HOPKINS·Filed 1985·Granted Jun 14, 1988·35 cites·14 claims
- 1374US2022170017A1In vivo delivery of oligonucleotidesONCOLMMUNIN INC·Filed 2022·Application pending·0 cites
- 1468US2022033815A1Systemic in vivo delivery of oligonucleotidesONCOIMMUNIN INC·Filed 2021·Application pending·0 cites
- 1563US4889916AProtein label and drug delivery systemUNIV JOHNS HOPKINS·Filed 1988·Granted Dec 26, 1989·22 cites·12 claims
- 1662US7312302B2Compositions for the detection of enzyme activity in biological samples and methods of use thereofONCOLMMUNIN INC·Filed 2001·Granted Dec 25, 2007·5 cites·37 claims
- 1761US2023065782A1Targeted and localized in vivo delivery of oligonucleotidesONCOIMMUNIN INC·Filed 2022·Application pending·0 cites
- 1860US2009325168A1Homo-doubly labeled compositions for the detection of enzyme activity in biological samplesONCOIMMUNIN INC·Filed 2009·Application pending·0 cites
- 1959US5055561AProtein label and drug delivery systemUNIV JOHNS HOPKINS·Filed 1989·Granted Oct 8, 1991·13 cites·6 claims
- 2057US2019183918A1Systemic in vivo delivery of oligonucleotidesONCOIMMUNIN INC·Filed 2018·Application pending·0 cites
- 2156US2016367587A1Systemic In Vivo Delivery of OligonucleotidesONCOLMMUNIN INC·Filed 2014·Application pending·0 cites
- 2256US2009263830A1Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markersONCOIMMUNIN INC·Filed 2009·Application pending·0 cites
- 2355US2003211548A1Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markersONCOLMMUNIN INC·Filed 2003·Application pending·0 cites
- 2453US2023201361A1Targeted and localized in vivo delivery of oligonucleotidesONCOLMMUNIN INC·Filed 2021·Application pending·0 cites
- 2540US5635356AAnti-oncoimmunin-M antibodies and uses thereofUS ARMY·Filed 1994·Granted Jun 3, 1997·4 cites·3 claims
- 2634US5364619AOncoimmuninsUS ARMY·Filed 1991·Granted Nov 15, 1994·3 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Akira Komoriya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →